Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Robert Laibovitz"'
Publikováno v:
Clinical Therapeutics. 18:821-832
The purpose of this study was to compare 2% dorzolamide three times daily with 2% pilocarpine four times daily to determine patient preference, tolerability, and impact on daily life in patients concurrently receiving 0.5% timolol twice daily for tre
Autor:
Ellen R. Strahlman, Roger Vogel, Robert Tipping, Coleen M. Clineschmidt, Richard Lewis, Edwin Keates, Harry Quigley, Thomas Zimmerman, Mark B. Abelson, Robert C. Allen, Reay H. Brown, Leonard R. Cacioppo, Marshall N. Cyrlin, David K. Gieser, Kevin C. Greenidge, Ronald L. Gross, David W. Karp, Melvyn M. Koby, Michael Kass, Robert Laibovitz, Charles D. McMahon, Charles S. Ostrov, Thomas Walters, Robert Ritch, John R. Samples, Joel S. Schuman, Janet Serle, M. Angela Vela-Thomas, Jacob Wilensky, Janet Boyle, Erik Lippa, Scott Reines, Kim Strohmaier
Publikováno v:
Ophthalmology. 103:1283-1293
Purpose: To report the results of two studies on the use of dorzolamide as adjunctive therapy to timolol in patients with elevated intraocular pressure (IOP). In the larger study, the additive effect of dorzolamide administered twice daily also was c
Autor:
Joseph Tauber, Peter Donshik, Garry Foulks, Harold Helms, Robert Laibovitz, Marta Lopatynsky, Earl Nelson, Peter Rapoza, Dara Stevenson
Publikováno v:
Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2 ISBN: 9781461374459
Keratoconjunctivitis sicca (KCS), or dry eye, is a common diagnosis, affecting approximately 30 million individuals worldwide. Patients with KCS experience symptoms associated with a chronic ocular irritation and often complain of a dry, gritty feeli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::930ef208893283cb83bba32d3b144557
https://doi.org/10.1007/978-1-4615-5359-5_138
https://doi.org/10.1007/978-1-4615-5359-5_138
Publikováno v:
Cornea. 12(4)
This trial was a randomized, double-masked, crossover study during which patients with keratoconjunctivitis sicca underwent 6 weeks of treatment with either cyclosporine 1% ophthalmic ointment or placebo followed by 6 weeks of the alternative treatme
Autor:
Coleen Clineschmidt, Ingrid Adamsons, Robert Laibovitz, Adam B. Polis, Jennifer Taylor, Arthur Shedden
Publikováno v:
Journal of Glaucoma. 7:247
PURPOSE Two parallel, randomized, double-masked, placebo-controlled studies were conducted to assess the efficacy and safety of 2% dorzolamide hydrochloride as adjunctive therapy to 0.5% timolol maleate ophthalmic gellan (gel-forming) solution in pat